(Stroke. 1999;30:2033-2037.)
© 1999 American Heart Association, Inc.
Original Contributions |
Should Stroke Victims Routinely Receive Supplemental Oxygen?
A Quasi-Randomized Controlled Trial
From the Foundation for Health Services Research, Central Hospital of Akershus, Nordbyhagen, Norway.
Correspondence and reprint requests to Ole Morten Rønning, Foundation for Health Services Research, HELTEF, Central Hospital of Akershus, 1474 Nordbyhagen, Norway. E-mail bguldvog{at}sia.pilot.akershus-f.kommune.no
 |
Abstract |
|---|
 Top Abstract IntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Background and Purpose—We sought to test the hypothesis that breathing 100% oxygen for the first 24 hours after an acute stroke would not reduce mortality, impairment, or disability.
Methods—Subjects admitted to the Central Hospital of Akershus, Norway, with stroke onset <24 hours before admittance were allocated to 2 groups by a quasi-randomized design using birth numbers. All patients with acute stroke admitted to hospital within 24 hours after a stroke were included and enrolled. Patients were allocated to a group that received supplemental oxygen treatment (100% atmospheres, 3 L/min) for 24 hours (n=292) or to the control group, which did not receive additional oxygen. Main outcome measures were 1-year survival, neurological impairment (Scandinavian Stroke Scale), and disability (Barthel Index) 7 months after stroke.
Results—One-year survival was 69% in the oxygen group and 73%
in the control group (OR 0.82; 95% CI 0.57 to 1.19;
P=0.30). Impairment scores and disability scores were
comparable 7 months after stroke. Among patients with Scandinavian
Stroke Scale (SSS) scores of 
40, 82% in the oxygen group and 91% in
the control group survived (OR 0.45; 95% CI 0.23 to 0.90;
P=0.023). For patients with SSS scores of <40, 53% in
the oxygen group and 48% in the control group survived (OR 1.26; 95%
CI 0.76 to 2.09; P=0.54).
Conclusions—Supplemental oxygen should not routinely be given to nonhypoxic stroke victims with minor or moderate strokes. Further research is needed to give conclusive advice concerning oxygen supplementation for patients with severe strokes.
Key Words: oxygen • stroke management • stroke outcome
|
Introduction |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
In both Norwegian and international guidelines for management of patients with acute ischemic stroke, the role of supplemental oxygen is questioned, although such treatment for hypoxic patients is recommended.1 2 Paramedics and staff in emergency clinics routinely give such treatment to all patients with acute stroke. Treatment is often continued within the hospital, regardless of whether the patient is hypoxic or not. There exists no empirical evidence for the benefit of this practice. Hyperoxia increases the formation of oxygen free radicals3 4 5 6 and induces cerebral vasoconstriction, which may reduce cerebral blood flow.7 Conflicting evidence exists about cerebral damage after ischemia caused by free radical formation and lipid peroxidation. Animal studies evaluating hyperbaric oxygen therapy have not been conclusive concerning recovery after cerebral ischemia.8 9 10 11 Two studies12 13 showed increased mortality among animals exposed to oxygen-enriched atmospheres.
Early mobilization is paramount in treatment of stroke patients,14 15 and thus it is important to reduce the number of procedures that prevent such mobilization. We hypothesized that supplemental oxygen was not effective to increase survival among stroke patients, nor to reduce impairment or disability. In particular, we hypothesized that patients with less-severe strokes would not benefit from supplemental oxygen, because ventilation among these patients is rarely impaired.
The study was performed to compare supplemental oxygen with no such treatment in patients with acute stroke of various severity, assessing the effect on survival, impairment, and disability.
|
Subjects and Methods |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Patients referred to the Central Hospital of Akershus, Norway, within 24 hours after onset of a stroke were prospectively enrolled in the study. The hospital serves a population of about 300 000. The study began March 1, 1994, and ended December 31, 1995. Stroke was defined according to WHO guidelines.16 Exclusion criteria were age <60 years and symptomatic onset of acute stroke >24 hours before admittance to hospital. Patients with subdural hematoma, subarachnoid hemorrhage, and transient ischemic attacks were excluded. Of all 570 patients admitted to the hospital with acute stroke in the study period, 550 patients (mean age 74.6 years; 53% men) were enrolled (Figure 1
). The 20 patients excluded from the
study did not comply with 1 or more of the inclusion criteria. Patients
were allocated to supplemental oxygen treatment or to no treatment
(control group) by a quasi-randomized design that was based on the date
of birth in the month. Patients with uneven digits in their date of
birth within the month (eg, 1, 3, 5
27, 29, 31) were allocated to the
control group and patients with even digits to the treatment group.
Stroke patients in the treatment group received 100% oxygen at
atmospheric pressure at a rate of 3 liters per minute through a nasal
catheter for 24 hours after they entered the hospital. Separate parts
of the stroke study, evaluating the effect of a stroke unit and a
hospital-based rehabilitation unit with respect to survival and
disability, are described elsewhere.17 18
|
The study was analyzed on an intention-to-treat basis. No patients were excluded from the study because they withdrew or because of pulmonary diseases or other conditions that could interfere with oxygen treatment. We chose to use intention-to treat-analysis because we were aware of the theoretical possibility that quasi-randomization based on birth digits could violate the requirement of a proper randomized study that all patients should have the same chance of receiving each treatment. Therefore, the protocol did not allow the admitting clinician to exclude patients with acute stroke from the study for any reason. If a patient was hypoxic or suffered from serious chronic obstructive lung disease, the physician responsible for the patient was instructed to give supplemental oxygen or not, as he found necessary, independent of the treatment to which the patient was allocated. Hence, we avoided introduction any systematic bias in this study. Informed consent regarding participation in this study was obtained from each patient or the next of kin. The experimental protocol was approved by the regional ethics committee. The research protocol contained ethical considerations stating that documentation of a benefit of oxygen therapy was lacking for stroke patients without respiratory insufficiency and that experiment was justified on this basis. A physician who was engaged in the investigation was involved when informed consent was obtained. Both the patients and the physician responsible for treatment could at any time withdraw the patient from the study or adjust the treatment. All of the patients (or the next of kin) who were asked accepted inclusion of the patient in the study.
Information on death was collected until March 1, 1997, through the National Register, an official register containing name, date of birth, address, and date of death. This register is continually updated. Impairment was assessed by Scandinavian Stroke Scale (SSS)19 score on admission and after 7 months. Disability was assessed by Barthel Index (BI)20 the first day after admittance and after 7 months. The initial assessment on admission was performed by the practitioner on duty, who also carried out the inclusion, assignment, and initiation of treatment. One of the investigators (O.M.R.) evaluated impairment and disability after 7 months (±1 month), without knowledge of the date of birth (and hence the treatment group) before the scoring. It has been recommended21 that outcome after stroke should be measured at 6 months because most significant recovery will be completed by that time.
We performed a subgroup analysis on patients with SSS 40 on
admission, in corroboration with our hypothesis that patients with
particularly moderate or minor strokes did not benefit from
supplemental oxygen. This analysis was prespecified, but we
chose 40 as the SSS score cutoff point after the start of the
study.
Thirty-three patients in the treatment group did not receive supplemental oxygen as prescribed. They were either not given such treatment or they received the treatment for <24 hours. Sixty-six patients in the control group were given oxygen treatment, but most of these patients were treated for considerably <24 hours. Eight of these patients had severe strokes and clinically impaired respiration and hence were offered supplemental oxygen.
Statistical Analysis
The associations between the normally distributed continuous
variables and treatment group were examined by using the unpaired
t test. The 
2 test was
used to investigate the association between the categorical
variables and the treatment group. Survival curves were plotted
with the Kaplan-Meier method. The log-rank test was used for
calculations of survival. Neurological and functional scores were
analyzed by the Mann-Whitney test. The study had 75% power in
tracing a 10% difference in mortality between the groups, given a 5%
significance level. The study was approved by the Regional Medical
Ethics Committee (approval No. S-93231) and by a local reference group
in the hospital.
|
Results |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Demographic characteristics and prior medical history did not differ significantly between the 2 groups (Table 1
), and the severity of stroke on
admission was comparable. Background data for patients with moderate
and minor strokes are also shown in Table 1. Table 2 shows the results for all patients in
the study. One-year survival was higher among the control patients but
failed to reach statistical significance (P=0,30). There was
no statistically significant difference between the groups concerning
neurological or disability score on follow-up.
|
|
Table 3 shows the outcomes separately for
stroke patients with SSS <40 and SSS 40. One-year survival was
higher in the control group than the treatment group for these patients
(P=0.023), but the groups did not differ in other outcomes.
If patients with hemorrhagic stroke were excluded from the
analysis, survival was still in favor of the control group (12
of 129 and 25 of 122, respectively; P=0.030). For patients
with severe stroke, there was a tendency for higher 1-year survival
among the patients who received oxygen supplementation (53%) than
among the control patients (48%), but the difference was not
statistically significant (P=0.60).
|
Figure 2 shows survival curves for the 2
treatment groups with all patients included; Figure 3 shows survival curves for
patients with mild or moderate strokes and patients with severe
strokes, by treatment group.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
The study shows that oxygen supplementation given as routine treatment does not appear to be of benefit for stroke victims. On the contrary, our study raises the hypothesis that oxygen supplementation to nonhypoxic patients with mild or moderate strokes may increase mortality. This is the first study of its kind to assess the effect of supplemental oxygen given routinely to patients with acute stroke and the first to show that oxygen supplementation to an unselected population of acute stroke patients does not seem to improve outcome. In our opinion, the practical consequence of our study is that nonhypoxic patients with moderate or minor strokes should not routinely receive supplemental oxygen after admission to the hospital. Our study is not conclusive regarding oxygen supplementation for patients with severe strokes. There was a tendency among these patients toward a benefit of oxygen supplementation, but the differences were statistically insignificant.
How could oxygen possibly contribute to worsening the prognosis for patients with moderate or minor strokes? We do not know the cause of these findings, even though there are some reports of a possible harmful effect of oxygen therapy.
One small controlled study did not show any effect of hyperbaric oxygenation after stroke whereas another study found that such treatment might worsen outcome.22 23 Controlled clinical studies of the effect of breathing an oxygen-enriched atmosphere has not been performed. One study of gerbils12 supports the hypothesis of damaging effects of oxygen supplementation. Several factors could contribute to this result. Free radicals of oxygen or reactive oxygen species and xanthine oxidase occur during reperfusion following ischemia.3 4 5 24 Mitochondrial respiration is impaired after ischemia,25 and an increase in molecular oxygen could theoretically result in an increase in reactive oxygen species, which could further result in tissue injury.26 In addition, oxygen supplementation by nasal catheter theoretically could reduce the opportunity of early mobilization in the treatment group, but we did not find differences in onset of mobilization between the groups.
Why could supplemental oxygen be of less harm among the patients with severe strokes? Some patients with severe strokes may have impaired respiration that is clinically undetectable and obviously could have benefited from supplemental oxygen. Further, such patients may have insufficient reperfusion of ischemic areas of the brain to allow a harmful effect of oxygen treatment, while the stroke patients who are less disabled on admission are those who have reperfusion of these areas. One possible damaging effect of supplemental oxygen could be dependent on this reperfusion, because reoxygenation of ischemic brain is a prerequisite for oxygen products that may participate in a postischemic neuronal damage. Because this is the first study of its kind, we recommend that the results be interpreted with caution. However, we have reason to believe that the possible damaging effect of supplemental oxygen may be even more pronounced than shown in our study, because some patients (n=33; 11%) allocated to the treatment group did not receive such treatment for a full 24 hours. In addition, some patients in the control group (n=66; 26%) were offered oxygen by paramedics before arrival at the hospital and/or in the emergency room.
Could our study be biased? The number of patients with odd and even birth numbers in the month admitted, and hence the number in the treatment group (n=292) and control group (n=258), were different. This difference in the occurrence of odd and even birth numbers among stroke patients admitted to hospital must have happened by chance. All patients who complied with the criteria were enrolled in the study, no referring doctor in the area knew about the randomization methods of the study, and the professional guidelines used by the primary health care and paramedics recommended that all patients with acute stroke should immediately be admitted to the hospital. Although we acknowledge the theoretical possibilities of bias with allocation based on the date of birth, we maintain that the allocation method in this case practically equals full randomization.
Through further investigation we intend to analyze the causes of death in the 2 groups, but a complete list of causes of death is not yet available. We do not know the duration or the threshold of the possible deleterious effect of breathing 100% oxygen through a nasal catheter. We recommend that further studies be performed to assess the effects of supplemental oxygen on patients with severe strokes. We believe, however, that our study probably gives sufficient documentation to recommend that supplemental oxygen should not be given routinely to patients with mild and moderate strokes.
Received May 31, 1999; revision received June 28, 1999; accepted June 28, 1999.
|
References |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
1. Norwegian Research Council. Treatment of Stroke Patients. Consensus Report No. 8. Oslo, Norway: Norwegian Research Council; 1995.
2. Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W. Guidelines for the management of patients with acute ischemic stroke. Stroke. 1994;25:1901–1914.[Medline] [Order article via Infotrieve]
3.
Hallenbeck J, Dutka A. Background review and current
concepts of reperfusion injury. Arch Neurol. 1990;47:1245–1254.
4. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159163.
5. Yasu T. H2 O2 generation in rat brain in vivo correlates with oxygen pressure [in Japanese, with English abstract]. Masui.. 1986;35:1077–1082.[Medline] [Order article via Infotrieve]
6. Yasu T, Crapo JD, Freeman BA. Hyperoxia enhances lung and liver nuclear uperoxide generation. Biochim Biophys Acta. 1984;798:167–174.[Medline] [Order article via Infotrieve]
7. Kety SS, Schmidt CF. The effects of altered tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J Clin Invest. 1984;27:484–492.
8.
Reitan J, Kien N, Thorup S, Corkill G. Hyperbaric
oxygen increases survival following carotid ligation in gerbils.
Stroke. 1990;21:119–123.
9. Takahashi M, Iwatsuki N, Ono K, Tajima T, Akama M, Koga Y. Hyperbaric oxygen therapy accelerates neurologic recovery after 15-minute complete global cerebral ischemia in dogs. Crit Care Med. 1992;20:1588–1594.[Medline] [Order article via Infotrieve]
10. Zwemer CF, Whitesall SE, D'Alecy LG. Cardiopulmonary-cerebral resuscitation with 100% oxygen exacerbates neurological dysfunction following nine minutes of cardiac arrest in dogs. Resuscitation. 1994;27:159–170.[Medline] [Order article via Infotrieve]
11. Mink R, Dutka A. Hyperbaric oxygen after global cerebral ischemia in rabbits does not promote brain lipid peroxidation. Crit Care Med. 1995;23:1398–1404.[Medline] [Order article via Infotrieve]
12.
Mickel HS, Vaishnav YN, Kempski O, von Lubitz D, Weiss
JF, Feuerstein G. Breathing 100% oxygen after global brain
ischemia in mongolian gerbils results in increased lipid
peroxidation and increased mortality. Stroke. 1987;18:426–430.
13.
Bromont C, Marie C, Bralet J. Increased
lipid peroxidation in vulnerable brain regions after transient
forebrain ischemia in rats. Stroke. 1989;20:918–924.
14. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet. 1993;342:395–398.[Medline] [Order article via Infotrieve]
15.
Indredavik B, Bakke F, Solberg R, Rokseth R, Haaheim
LL, Holme I. Benefit of a stroke unit: a randomized controlled trial.
Stroke. 1991;22:1026–1031.
16. WHO Special Report. Stroke–1989: recommendations on stroke prevention, diagnosis, and therapy. Stroke. 1989;1989:20:1407–1431.
17.
Rønning OM, Guldvog B. Stroke unit versus general
medical wards, I: twelve- and eighteen-month survival: a randomized
controlled trial. Stroke. 1998;29:58–62.
18.
Rønning OM, Guldvog B. Outcome of subacute stroke
rehabilitation: a randomized controlled trial. Stroke. 1998;29:779–784.
19.
Scandinavian Stroke Study Group. Multicenter trial of
hemodilution in acute ischemic stroke: background and study
protocol. Stroke. 1985;16:885–890.
20. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61–65.[Medline] [Order article via Infotrieve]
21. Wade DT. Evaluating outcome in stroke rehabilitation (quality control and clinical audit). Scand J Rehab Med Suppl. 1992;26:97–104.[Medline] [Order article via Infotrieve]
22.
Anderson DC, Bottini AG, Jagiella WM, Westphal B, Ford
S, Rockswold GL, Loewenson RB. A pilot study of hyperbaric oxygen in
the treatment of human stroke. Stroke. 1991;22:1137–1142.
23.
Nighoghossian N, Trouillas P, Salord F. Hyperbaric
oxygen in the treatment of acute ischemic stroke: a
double-blind pilot study. Stroke. 1995;26:1369–1372.
24. Kinuta Y, Kimura M, Itokawa Y, Ishikawa M, Kikuchi H. Changes in xanthine oxidase in ischemic rat brain. J Neurosurg. 1989;71:417–420.[Medline] [Order article via Infotrieve]
25. Hartung KJ, Jung K. Mitochondrial respiratory function as an indicator of the ischemic injury of the rat kidney. Biomed Biochim Acta. 1985;44:1435–1443.[Medline] [Order article via Infotrieve]
26. Halliwell B, Gutteridge JMC. Lipid peroxidation, oxygen radicals, cell damage, and antioxydant therapy. Lancet. 1984;1:1396–1397.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  M. Wijesinghe, P. Shirtcliffe, K. Perrin, B. Healy, K. James, M. Weatherall, and R. Beasley An audit of the effect of oxygen prescription charts on clinical practice Postgrad. Med. J., February 1, 2010; 86(1012): 89 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Summers, A. Leonard, D. Wentworth, J. L. Saver, J. Simpson, J. A. Spilker, N. Hock, E. Miller, P. H. Mitchell, and on behalf of the American Heart Association Counci Comprehensive Overview of Nursing and Interdisciplinary Care of the Acute Ischemic Stroke Patient: A Scientific Statement From the American Heart Association Stroke, August 1, 2009; 40(8): 2911 - 2944. [Full Text] [PDF]
|
|
|
|
 |
|
 R Novakovic, G Toth, and P D Purdy Review of current and emerging therapies in acute ischemic stroke JNIS, July 1, 2009; 1(1): 13 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R M Leach and A C Davidson Use of emergency oxygen in adults BMJ, January 20, 2009; 338(jan20_1): a2790 - a2790. [Full Text]
|
|
|
|
 |
|
 K E Hale, C Gavin, and B R O'Driscoll Audit of oxygen use in emergency ambulances and in a hospital emergency department Emerg. Med. J., November 1, 2008; 25(11): 773 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B R O'Driscoll, L S Howard, A G Davison, and on behalf of the British Thoracic Society BTS guideline for emergency oxygen use in adult patients Thorax, October 1, 2008; 63(Suppl_6): vi1 - vi68. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Zaharchuk, A.J. Martin, and W.P. Dillon Noninvasive Imaging of Quantitative Cerebral Blood Flow Changes during 100% Oxygen Inhalation Using Arterial Spin-Labeling MR Imaging AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 663 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Sun, H. H. Marti, and R. Veltkamp Hyperbaric Oxygen Reduces Tissue Hypoxia and Hypoxia-Inducible Factor-1{alpha} Expression in Focal Cerebral Ischemia Stroke, March 1, 2008; 39(3): 1000 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Beasley, S. Aldington, and G. Robinson Is it time to change the approach to oxygen therapy in the breathless patient? Thorax, October 1, 2007; 62(10): 840 - 841. [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Shin, A. K. Dunn, P. B. Jones, D. A. Boas, E. H. Lo, M. A. Moskowitz, and C. Ayata Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia Brain, June 1, 2007; 130(6): 1631 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, May 22, 2007; 115(20): e478 - e534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Stroke, May 1, 2007; 38(5): 1655 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. H. Chiu, C.-S. Liu, T.-Y. Tan, and K.-C. Chang Venturi mask adjuvant oxygen therapy in severe acute ischemic stroke. Arch Neurol, May 1, 2006; 63(5): 741 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Part 9: Adult Stroke Circulation, December 13, 2005; 112(24_suppl): IV-111 - IV-120. [Full Text] [PDF]
|
|
|
|
|
|
Part 9: Stroke Circulation, November 29, 2005; 112(22_suppl): III-110 - III-104. [Full Text] [PDF]
|
|
|
|
|
|
A. B. Singhal, T. Benner, L. Roccatagliata, W. J. Koroshetz, P. W. Schaefer, E. H. Lo, F. S. Buonanno, R. G. Gonzalez, and A. G. Sorensen A Pilot Study of Normobaric Oxygen Therapy in Acute Ischemic Stroke Stroke, April 1, 2005; 36(4): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. de la Morandiere and D. Walter Oxygen therapy in acute stroke Emerg. Med. J., November 1, 2003; 20(6): 547 - 547. [Abstract] [Full Text]
|
|
|
|
|
|
C. Roffe, S. Sills, M. Halim, K. Wilde, M. B. Allen, P. W. Jones, and P. Crome Unexpected Nocturnal Hypoxia in Patients With Acute Stroke Stroke, November 1, 2003; 34(11): 2641 - 2645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Adams Jr, R. J. Adams, T. Brott, G. J. del Zoppo, A. Furlan, L. B. Goldstein, R. L. Grubb, R. Higashida, C. Kidwell, T. G. Kwiatkowski, et al. Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association Stroke, April 1, 2003; 34(4): 1056 - 1083. [Full Text] [PDF]
|
|
|
|
|
|
A. J Thomson, D. J Webb, S. R J Maxwell, and I. S Grant Oxygen therapy in acute medical care BMJ, June 15, 2002; 324(7351): 1406 - 1407. [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Singhal, R. M. Dijkhuizen, B. R. Rosen, and E. H. Lo Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke Neurology, March 26, 2002; 58(6): 945 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Pancioli, M. J. Bullard, M. E. Grulee, E. C. Jauch, and D. F. Perkis Supplemental Oxygen Use in Ischemic Stroke Patients: Does Utilization Correspond to Need for Oxygen Therapy? Arch Intern Med, January 14, 2002; 162(1): 49 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Roffe, S. Sills, K. Wilde, and P. Crome Effect of Hemiparetic Stroke on Pulse Oximetry Readings on the Affected Side Stroke, August 1, 2001; 32(8): 1808 - 1810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bhalla, C.D.A. Wolfe, and A.G. Rudd Management of acute physiological parameters after stroke QJM, March 1, 2001; 94(3): 167 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sinha and E.A. Warburton The evolution of stroke units--towards a more intensive approach? QJM, September 1, 2000; 93(9): 633 - 638. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||